Lakshminarayana Vogeti

USPTO Granted Patents = 20 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 365(Granted Patents)

Location History:

Arlington, MA (US) (2015 - 2016)
Lawrence, KS (US) (2015 - 2023)
Waltham, MA (US) (2022 - 2024)

Company Filing History:

12 out of 84

Deciphera Pharmaceuticals, LLC

patents

8 out of 81

Biocryst Pharmaceuticals, Inc.

patents

1 out of 4,442

Eli Lilly and Company

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12485109 - Pyrrolo 12.3-dipyrimidine compounds and analogues thereof (2025-12-02),

2. 12377097 - Aminopyrimidine amide autophagy inhibitors and methods of use thereof (2025-08-05),

3. 12319655 - RAF kinase inhibitors and methods of use thereof (2025-06-03),

4. 12071432 - Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof (2024-08-27),

5. 11807605 - Human plasma kallikrein inhibitors (2023-11-07),

6. 11618731 - Prodrugs of kallikrein inhibitors (2023-04-04),

7. 11590134 - Aminopyrimidine amide autophagy inhibitors and methods of use thereof (2023-02-28),

8. 11559515 - Indole compounds and analogues thereof (2023-01-24),

9. 11530206 - Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof (2022-12-20),

10. 11518758 - Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof (2022-12-06),

11. 11066360 - Human plasma kallikrein inhibitors (2021-07-20),

12. 10849883 - Benzopyrazole compounds and analogues thereof (2020-12-01),

13. 10759759 - Prodrugs of kallikrein inhibitors (2020-09-01),

14. 10562850 - Human plasma kallikrein inhibitors (2020-02-18),

15. 9382228 - N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities (2016-07-05),

Title: Lakshminarayana Vogeti: Pioneering Innovations in Biopharmaceuticals

Introduction:

Lakshminarayana Vogeti, a prominent inventor based in Lawrence, KS (US), is renowned for his innovative spirit and dedication to advancing technology in the realm of biopharmaceuticals. With a commendable portfolio of 16 patents, Vogeti is setting new standards in shaping the landscape of innovation.

Latest Patents:

Vogeti's latest patents include groundbreaking inventions in the field of biopharmaceuticals. One of his remarkable creations is the development of Human plasma kallikrein inhibitors, which are compounds designed to inhibit plasma kallikrein and hold promising implications for treating diseases characterized by unwanted plasma kallikrein activity. Additionally, Vogeti has also introduced Prodrugs of kallikrein inhibitors, aimed at combatting acquired or hereditary angioedema and other conditions associated with aberrant kallikrein activity.

Career Highlights:

Having made significant contributions to the field, Vogeti has worked with reputable companies such as Deciphera Pharmaceuticals, LLC, and Biocryst Pharmaceuticals, Inc. His innovative work within these organizations has paved the way for groundbreaking solutions in biopharmaceutical research and development.

Collaborations:

Throughout his career, Vogeti has collaborated with esteemed professionals in the industry, including his coworkers Daniel L. Flynn and Timothy Malcolm Caldwell. These collaborations have not only enriched his inventive journey but have also fostered a culture of shared knowledge and expertise within the field of biopharmaceuticals.

Conclusion:

In conclusion, Lakshminarayana Vogeti's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have positioned him as a standout figure in the world of inventors. With a promising future ahead, Vogeti continues to shape the landscape of biopharmaceutical innovation, leaving a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.